Report
Our reports provide latest industry trends, forecasts, company profiles, competitive landscape, and strategic insights.
Manufacturing Execution System in Life Sciences Market Forecast to 2033 - COVID-19 Impact and Global Analysis By Offering (Software and Services), Deployment (On-Premises and Cloud), Organization Size (SMEs and Large Enterprises), and Application (Pharmaceutical, Biotechnology, and Medical Devices)
- Report Code : TIPRE00029831
- Pages : 214
The manufacturing execution system in life sciences market value is projected to reach US$ 10,456.54 million by 2033 from US$ 3,139.14 million in 2022; it is expected to grow at a CAGR of 12.0% during 2023–2033.
An MES is typically optimized for complex production processes with frequent bottlenecks and limited capacity to deal with alternative paths in production. For example, in February 2022, Integer, a medical device outsourcing (MDO) manufacturer, selected Critical Manufacturing’s execution system (MES) to enhance the quality and efficiency of its global production processes. The company will implement this module at its site in Ireland to digitalize its production processes; gather real-time data; and add efficiency, quality, and traceability. Moreover, pharmaceutical manufacturers are under continuous pressure to remain competitive while meeting stringent regulatory requirements. The use of an MES aids in fulfilling regulatory and data integrity requirements and is key to the digitalization of manufacturing plants. The manufacturing execution system in life sciences market growth can be attributed to the increasing implementation due to the requirement of real-time data in the production management process. However, the lack of flexibility of the software is likely to affect the manufacturing execution system in life sciences market growth during the forecast period.
The Manufacturing Execution System in the Life Science market trends include Shift from Legacy to Modern MES
Modern MES solutions are an advanced and lighter version of MES. They help enhance production processes in pharmaceutical industries without the need for custom coding. Modern MES provides digital production records and automated workflows that foster right-first-time batches, which further help increase plant efficiency. In addition, the fast and flexible responsiveness of the modern MES solution makes it easier to modify production lines and accommodate small batches. These solutions provide real-time visibility by helping retrieve data from local and remote locations. Thus, various pharma companies are shifting to modern MES solutions to develop high-quality pharmaceutical products and enhance production performance. Tulip’s Next Gen MES, MasterControl’s MES, 42Q’s MES 101, and EIS’s OpsTrakker Solution Suite are a few of the examples of modern MES solutions. Bristol-Myers Squibb, Synthego Corporation, Sri Krishna Pharmaceuticals Limited, EpiBone, and Fagron NV are among the users of these modern MES solutions.
Modern MES solutions adopt more aspects of enterprise resource planning (ERP) platforms. This allows them to provide better material identity and logistics tracking, and integration with the production operations, together with a distributed model that goes beyond traditional production. On the other hand, traditional MES solutions are focused on batch manufacturing and are often incapable of necessary capabilities without significant customization. Such factors are expected to boost the popularity of modern manufacturing execution systems among life sciences players during the forecast period.
Manufacturing execution system in life sciences market share of Asia pacific region holds a substantial share of the market. India and China are among the largest producers of generic drugs. Moreover, India is one of the largest exporters of generic medicines in the world, consisting of various prominent generic drug manufacturers such as Sun Pharmaceutical Industries Ltd, Aurobindo Pharma, and Cipla. The presence of such major drug manufacturers in the region would fuel the demand for MES solutions to track the manufacturing process. Large Enterprises’ adoption rates are among the factors contributing to the growing manufacturing execution system in life sciences market size.
Korber AG, Siemens AG, General Electric, Emerson Electric, Schneider, Rockwell Automation, Apprentice FS Inc, ATS Global, Atachi Systems, LZ Lifescience Ltd, POMS Corporation, and Schneider Electric are among the key manufacturing execution system in life sciences market players.
The overall manufacturing execution system in life sciences market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. The process also serves the purpose of obtaining an overview and forecast of the manufacturing execution system in life sciences market size with respect to all market segments. Multiple primary interviews have been conducted with industry participants and commentators to validate the data and gain more analytical insights. Participants of this process include VPs; business development managers; market intelligence managers; national sales managers; and external consultants such as valuation experts, research analysts, and key opinion leaders, specializing in the manufacturing execution system in life sciences market.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Manufacturing Execution System in Life Sciences Market – By Offering
1.3.2 Global Manufacturing Execution System in Life Sciences Market – By Deployment
1.3.3 Global Manufacturing Execution System in Life Sciences Market – By Organization Size
1.3.4 Global Manufacturing Execution System in Life Sciences Market – By Application
1.3.5 Global Manufacturing Execution System in Life Sciences Market – By Geography
2. Manufacturing Execution System in Life Sciences Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Manufacturing Execution System in Life Sciences Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America
4.2.2 Europe
4.2.3 Asia Pacific
4.2.4 Middle East and Africa
4.2.5 South America
4.3 Ecosystem Analysis
4.4 Expert Opinion
4.5 Premium Insights
4.5.1 MES Market Analysis, By Function
4.5.1.1 Data collection and Acquisition:
4.5.1.2 Labor Management:
4.5.1.3 Process Management:
4.5.1.4 Performance Analysis:
4.5.1.5 Document Control:
4.5.1.6 Dispatching and Production:
4.5.2 Future of MES
4.5.3 Start-Up Landscape
4.5.4 Competitive Benchmarking
4.5.5 End User/Customer’s Vision
4.5.6 Light MES: Market Analysis
4.5.6.1 Light MES in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
4.5.6.2 Light MES vs Standard MES
4.5.7 Light MES Products for Life Sciences Industry
4.5.8 Leading MES Products for Life Sciences Industry
4.5.9 MES Service Providers/System Integrators for Life Sciences Industry
4.5.10 MES Solutions Used by Major Life Sciences Companies
5. Manufacturing Execution System in Life Sciences Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Need for Compliance with Regulatory Framework
5.1.2 Requirement of Accurate Real-Time Data in Production Management Process
5.2 Market Restraints
5.2.1 High Cost and Lack of Flexibility
5.3 Market Opportunities
5.3.1 Rising Application in Cell and Gene Therapy Sector
5.4 Future Trends
5.4.1 Shift from Legacy to Modern MES
5.4.2 Rise in Adoption of Pharma 4.0
5.5 Impact Analysis of Drivers and Restraints
6. Manufacturing Execution System in Life Sciences Market – Global Analysis
6.1 Global Manufacturing Execution System in Life Sciences Market Overview
6.2 Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
6.3 Company Market Share Analysis
7. Manufacturing Execution System in Life Sciences Market Analysis – By Offering
7.1 Overview
7.2 Manufacturing Execution System in Life Sciences Market, By Offering (2022 and 2033)
7.3 Software
7.3.1 Overview
7.3.2 Software: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
7.4 Services
7.4.1 Overview
7.4.2 Services: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
8. Manufacturing Execution System in Life Sciences Market Analysis – By Deployment
8.1 Overview
8.2 Manufacturing Execution System in Life Sciences Market, By Deployment (2022 and 2033)
8.3 On-Premises
8.3.1 Overview
8.3.2 On-Premises: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
8.4 Cloud
8.4.1 Overview
8.4.2 Cloud: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
9. Manufacturing Execution System in Life Sciences Market Analysis – By Organization Size
9.1 Overview
9.2 Manufacturing Execution System in Life Sciences Market, By Organization Size (2022 and 2033)
9.3 SMEs
9.3.1 Overview
9.3.2 SMEs: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
9.4 Large Enterprises
9.4.1 Overview
9.4.2 Large Enterprises: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
10. Manufacturing Execution System in Life Sciences Market Analysis – By Application
10.1 Overview
10.2 Manufacturing Execution System in Life Sciences Market, By Application (2022 and 2033)
10.3 Pharmaceutical
10.3.1 Overview
10.3.2 Pharmaceutical: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
10.4 Biotechnology
10.4.1 Overview
10.4.2 Biotechnology: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
10.5 Medical Devices
10.5.1 Overview
10.5.2 Medical Devices: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
11. Manufacturing Execution System in Life Sciences Market Analysis – By Region
11.1 North America: Manufacturing Execution System in Life Sciences Market
11.1.1 Overview
11.1.2 North America: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.3 North America: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.1.4 North America: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.1.5 North America: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.1.6 North America: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.1.7 North America: Manufacturing Execution System in Life Sciences Market, by Country, 2022 & 2033 (%)
11.1.7.1 US: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.7.1.1 Overview
11.1.7.1.2 US: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.7.1.3 US: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.1.7.1.4 US: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.1.7.1.5 US Manufacturing Execution System in Life Sciences Market, by Organization Size, 2022–2033 (US$ Million)
11.1.7.1.6 US Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.1.7.2 Canada: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.7.2.1 Overview
11.1.7.2.2 Canada: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.7.2.3 Canada: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.1.7.2.4 Canada: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.1.7.2.5 Canada: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.1.7.2.6 Canada Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.1.7.3 Mexico: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.7.3.1 Overview
11.1.7.3.2 Mexico: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.1.7.3.3 Mexico: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.1.7.3.4 Mexico: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.1.7.3.5 Mexico Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.2 Europe: Manufacturing Execution System in Life Sciences Market
11.2.1 Overview
11.2.2 Europe: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.3 Europe: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.2.4 Europe: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.2.5 Europe: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.2.6 Europe: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.2.7 Europe: Manufacturing Execution System in Life Sciences Market, by Country, 2022 & 2033 (%)
11.2.7.1 Germany: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.7.1.1 Overview
11.2.7.1.2 Germany: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.7.1.3 Germany: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.2.7.1.4 Germany: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.2.7.1.5 Germany: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.2.7.1.6 Germany Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.2.7.2 France: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.7.2.1 Overview
11.2.7.2.2 France: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.7.2.3 France: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.2.7.2.4 France: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.2.7.2.5 France: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.2.7.2.6 France Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.2.7.3 Italy: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.7.3.1 Overview
11.2.7.3.2 Italy: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.7.3.3 Italy: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.2.7.3.4 Italy: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.2.7.3.5 Italy: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.2.7.3.6 Italy Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.2.7.4 UK: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.7.4.1 Overview
11.2.7.4.2 UK: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.7.4.3 UK: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.2.7.4.4 UK: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.2.7.4.5 UK: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.2.7.4.6 UK Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.2.7.5 Spain: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.7.5.1 Overview
11.2.7.5.2 Spain: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.7.5.3 Spain: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.2.7.5.4 Spain: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.2.7.5.5 Spain: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.2.7.5.6 Spain Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.2.7.6 Rest of Europe: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.7.6.1 Overview
11.2.7.6.2 Rest of Europe: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.2.7.6.3 Rest of Europe: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.2.7.6.4 Rest of Europe: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.2.7.6.5 Rest of Europe: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.2.7.6.6 Rest of Europe Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.3 Asia Pacific: Manufacturing Execution System in Life Sciences Market
11.3.1 Overview
11.3.2 Asia Pacific: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.3 Asia Pacific: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.3.4 Asia Pacific: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.3.5 Asia Pacific: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.3.6 Asia Pacific: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.3.7 Asia Pacific: Manufacturing Execution System in Life Sciences Market, by Country, 2022 & 2033 (%)
11.3.7.1 Australia: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.7.1.1 Overview
11.3.7.1.2 Australia: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.7.1.3 Australia: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.3.7.1.4 Australia: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.3.7.1.5 Australia: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.3.7.1.6 Australia: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.3.7.2 China: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.7.2.1 Overview
11.3.7.2.2 China: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.7.2.3 China: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.3.7.2.4 China: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.3.7.2.5 China: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.3.7.2.6 China Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.3.7.3 India: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.7.3.1 Overview
11.3.7.3.2 India: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.7.3.3 India: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.3.7.3.4 India: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.3.7.3.5 India: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.3.7.3.6 India: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.3.7.4 Japan: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.7.4.1 Overview
11.3.7.4.2 Japan: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.7.4.3 Japan: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.3.7.4.4 Japan: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.3.7.4.5 Japan: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.3.7.4.6 Japan: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.3.7.5 South Korea: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.7.5.1 Overview
11.3.7.5.2 South Korea: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.7.5.3 South Korea: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.3.7.5.4 South Korea: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.3.7.5.5 South Korea: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.3.7.5.6 South Korea: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.3.7.6 Rest of Asia Pacific: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.7.6.1 Overview
11.3.7.6.2 Rest of Asia Pacific: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.3.7.6.3 Rest of Asia Pacific: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.3.7.6.4 Rest of Asia Pacific: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.3.7.6.5 Rest of Asia Pacific: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.3.7.6.6 Rest of Asia Pacific: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.4 Middle East and Africa: Manufacturing Execution System in Life Sciences Market
11.4.1 Overview
11.4.2 Middle East and Africa: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.4.3 Middle East and Africa: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.4.4 Middle East and Africa: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.4.5 Middle East and Africa: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.4.6 Middle East and Africa: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.4.7 Middle East and Africa: Manufacturing Execution System in Life Sciences Market, by Country, 2022 & 2033 (%)
11.4.7.1 South Africa: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.4.7.1.1 Overview
11.4.7.1.2 South Africa: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.4.7.1.3 South Africa: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.4.7.1.4 South Africa: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.4.7.1.5 South Africa: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.4.7.1.6 South Africa: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.4.7.2 Saudi Arabia: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.4.7.2.1 Overview
11.4.7.2.2 Saudi Arabia: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.4.7.2.3 Saudi Arabia: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.4.7.2.4 Saudi Arabia: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.4.7.2.5 Saudi Arabia: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.4.7.2.6 Saudi Arabia: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.4.7.3 UAE: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.4.7.3.1 Overview
11.4.7.3.2 UAE: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.4.7.3.3 UAE: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.4.7.3.4 UAE: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.4.7.3.5 UAE: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.4.7.3.6 UAE: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.4.7.4 Rest of Middle East & Africa: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.4.7.4.1 Overview
11.4.7.4.2 Rest of Middle East & Africa: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.4.7.4.3 Rest of Middle East and Africa: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.4.7.4.4 Rest of Middle East and Africa: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.4.7.4.5 Rest of Middle East and Africa: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.4.7.4.6 Rest of Middle East and Africa: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.5 South America: Manufacturing Execution System in Life Sciences Market
11.5.1 Overview
11.5.2 South America: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.5.3 South America: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.5.4 South America: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.5.5 South America: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.5.6 South America: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.5.7 South America: Manufacturing Execution System in Life Sciences Market, by Country, 2022 & 2033 (%)
11.5.7.1 Brazil: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.5.7.1.1 Overview
11.5.7.1.2 Brazil: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.5.7.1.3 Brazil: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.5.7.1.4 Brazil: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.5.7.1.5 Brazil: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.5.7.1.6 Brazil: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.5.7.2 Argentina: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.5.7.2.1 Overview
11.5.7.2.2 Argentina: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.5.7.2.3 Argentina: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.5.7.2.4 Argentina: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.5.7.2.5 Argentina: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.5.7.2.6 Argentina: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
11.5.7.3 Rest of South & Central America: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.5.7.3.1 Overview
11.5.7.3.2 Rest of South & Central America: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
11.5.7.3.3 Rest of South America: Manufacturing Execution System in Life Sciences Market, by Offering, 2022–2033 (US$ Million)
11.5.7.3.4 Rest of South America: Manufacturing Execution System in Life Sciences Market, by Deployment, 2022–2033 (US$ Million)
11.5.7.3.5 Rest of South America: Manufacturing Execution System in Life Sciences Market, Organization Size, 2022–2033 (US$ Million)
11.5.7.3.6 Rest of South America: Manufacturing Execution System in Life Sciences Market, by Application, 2022–2033 (US$ Million)
12. Industry Landscape
12.1 Overview
12.2 Market Initiatives, Expansions, and Strategic Developments
12.3 New Product/Feature Development
12.4 Mergers and Acquisitions
12.5 Agreements, Collaborations, and Joint Ventures
13. Company Profiles
13.1 Apprentice FS Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 ATS Global B.V.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Atachi Systems
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Emerson Electric Co
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 LZ Lifescience Limited
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Korber AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 POMS Corporation
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Rockwell Automation Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Schneider Electric SE
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Siemens AG
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Word Index
LIST OF TABLES
Table 1. Start-Ups
Table 2. Competitive Benchmarking (2022)
Table 3. Light MES in Life Sciences Market, By Geography – Revenue and Forecast to 2023 (US$ Million)
Table 4. Light MES vs Standard MES
Table 5. Light MES Products for Life Sciences Industry
Table 6. Leading MES Products for Life Sciences Industry
Table 7. MES Service Providers/System Integrators for Life Sciences Industry
Table 8. MES Solutions Used by Major Pharma/Biopharma Companies
Table 9. MES Solutions Used by Major Medical Device Manufacturers
Table 10. Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2023 (US$ Million)
Table 11. North America Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 12. North America Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 13. North America Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 14. North America Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 15. US Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 16. US Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 17. US Manufacturing Execution System in Life Sciences Market, by Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 18. US Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 19. Canada Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 20. Canada Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 21. Canada Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 22. Canada Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 23. Mexico Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 24. Mexico Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 25. Mexico Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 26. Mexico Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 27. Europe Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 28. Europe Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 29. Europe Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 30. Europe Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 31. Germany Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 32. Germany Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 33. Germany Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 34. Germany Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 35. France Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 36. France Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 37. France Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 38. France Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 39. Italy Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 40. Italy Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 41. Italy Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 42. Italy Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 43. UK Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 44. UK Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 45. UK Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 46. UK Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 47. Spain Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 48. Spain Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 49. Spain Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 50. Spain Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 51. Rest of Europe Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 52. Rest of Europe Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 53. Rest of Europe Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 54. Rest of Europe Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 55. Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 56. Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 57. Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 58. Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 59. Australia Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 60. Australia Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 61. Australia Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 62. Australia Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 63. China Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 64. China Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 65. China Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 66. China Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 67. India Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 68. India Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 69. India Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 70. India Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 71. Japan Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 72. Japan Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 73. Japan Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 74. Japan Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 75. South Korea Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 76. South Korea Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 77. South Korea Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 78. South Korea Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 79. Rest of Asia Pacific Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 80. Rest of Asia Pacific Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 81. Rest of Asia Pacific Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 82. Rest of Asia Pacific Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 83. Middle East and Africa Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 84. Middle East and Africa Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 85. Middle East and Africa Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 86. Middle East and Africa Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 87. South Africa Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 88. South Africa Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 89. South Africa Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 90. South Africa Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 91. Saudi Arabia Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 92. Saudi Arabia Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 93. Saudi Arabia Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 94. Saudi Arabia Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 95. UAE Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 96. UAE Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 97. UAE Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 98. UAE Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 99. Rest of Middle East and Africa Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 100. Rest of Middle East and Africa Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 101. Rest of Middle East and Africa Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 102. Rest of Middle East and Africa Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 103. South America Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 104. South America Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 105. South America Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 106. South America Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 107. Brazil Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 108. Brazil Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 109. Brazil Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 110. Brazil Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 111. Argentina Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 112. Argentina Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 113. Argentina Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 114. Argentina Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 115. Rest of South America Manufacturing Execution System in Life Sciences Market, by Offering – Revenue and Forecast to 2033 (US$ Million)
Table 116. Rest of South America Manufacturing Execution System in Life Sciences Market, by Deployment – Revenue and Forecast to 2033 (US$ Million)
Table 117. Rest of South America Manufacturing Execution System in Life Sciences Market, Organization Size – Revenue and Forecast to 2033 (US$ Million)
Table 118. Rest of South America Manufacturing Execution System in Life Sciences Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 119. List of Abbreviation
LIST OF FIGURES
Figure 1. Manufacturing Execution System in Life Sciences Market Segmentation
Figure 2. Manufacturing Execution System in Life Sciences Market Segmentation, By Region
Figure 3. Global Manufacturing Execution System in Life Sciences Market Overview
Figure 4. Services Held Largest Share Of Offering Segment In Manufacturing Execution System in Life Sciences Market
Figure 5. On Premises Held Largest Share Of Deployment Segment In Manufacturing Execution System in Life Sciences Market
Figure 6. Large Enterprises Held Largest Share Of Organization Size Segment In Manufacturing Execution System in Life Sciences Market
Figure 7. Medical Device Held Largest Share Of Application Segment In Manufacturing Execution System in Life Sciences Market
Figure 8. Asia Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South America: PEST Analysis
Figure 14. Expert Opinion
Figure 15. Light MES in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 16. Manufacturing Execution System in Life Sciences Market: Impact Analysis of Drivers and Restraints
Figure 17. Geographic Overview of Manufacturing Execution System in Life Sciences Market
Figure 18. Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 19. MES in Life Sciences Market – Global Market Share (2022)
Figure 20. MES in Life Sciences Market – Company Market Share for Pharma/Bio-Pharma Solutions (2022)
Figure 21. MES in Life Sciences Market – Company Market Share for Pharma/Bio-Pharma Services (2022)
Figure 22. MES in Life Sciences Market – Company Market Share for Medical Devices Solutions (2022)
Figure 23. MES in Life Sciences Market – Company Market Share for Medical Devices Services (2022)
Figure 24. Manufacturing Execution System in Life Sciences Market Revenue Share, By Offering (2022 and 2033)
Figure 25. Software: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 26. Services: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 27. Manufacturing Execution System in Life Sciences Market Revenue Share, By Deployment (2022 and 2033)
Figure 28. On-Premises: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 29. Cloud: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 30. Manufacturing Execution System in Life Sciences Market Revenue Share, By Organization Size (2022 and 2033)
Figure 31. SMEs: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 32. Large Enterprises: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 33. Manufacturing Execution System in Life Sciences Market Revenue Share, By Application (2022 and 2033)
Figure 34. Pharmaceutical: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 35. Biotechnology: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 36. Medical Devices: Manufacturing Execution System in Life Sciences Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 37. North America: Manufacturing Execution System in Life Sciences Market, by Key Country – Revenue (2022) (US$ Million)
Figure 38. North America Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 39. US: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 40. Canada: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 41. Mexico: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 42. Europe: Manufacturing Execution System in Life Sciences Market, by Key Country – Revenue (2022) (US$ Million)
Figure 43. Europe Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 44. Germany: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 45. France: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 46. Italy: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 47. UK: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 48. Spain: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 49. Rest of Europe: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 50. Asia Pacific: Manufacturing Execution System in Life Sciences Market, by Key Country – Revenue (2022) (US$ Million)
Figure 51. Asia Pacific Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 52. Australia: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 53. China: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 54. India: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 55. Japan: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 56. South Korea: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 57. Rest of Asia Pacific: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 58. Middle East and Africa: Manufacturing Execution System in Life Sciences Market, by Key Country – Revenue (2022) (US$ Million)
Figure 59. Middle East and Africa Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 60. South Africa: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 61. Saudi Arabia: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 62. UAE: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 63. Rest of Middle East & Africa: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 64. South America: Manufacturing Execution System in Life Sciences Market, by Key Country – Revenue (2022) (US$ Million)
Figure 65. South America Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 66. Brazil: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 67. Argentina: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
Figure 68. Rest of South & Central America: Manufacturing Execution System in Life Sciences Market – Revenue and Forecast to 2033 (US$ Million)
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the manufacturing execution system in life sciences market
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations such as specific country and segmental insight highlights crucial progressive industry trends in the manufacturing execution system in life sciences market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
The List of Companies – Manufacturing Execution System in Life Sciences Market
• Korber AG
• Siemens AG
• Emerson Electric
• Schneider Electric
• Rockwell Automation
• Apprentice FS Inc
• ATS Global
• Atachi Systems
• LZ Lifescience Ltd
• POMS Corporation
According to the new research report on “Manufacturing Execution System in Life Sciences Market Forecast to 2033 – Global Analysis – by Offering, Deployment, Organization Size, and Application” published by The Insight Partners, the market value is expected to reach US$ 10,456.54 million by 2033, registering a CAGR of 12.0% from 2023 to 2033.
In terms of revenue, Europe held the second largest manufacturing execution system in life sciences market share for the year 2022. Europe includes well-established economies such as France, Germany, Russia, the UK, and Italy. The region houses a few of the major medical device manufacturers, and the medical device industry in the region has exhibited several cases of MES deployment in the past few years. As medical device companies are embracing digitalization in areas ranging from factory floor automation to back-office administration to enhance efficiency in all departments. There is a growing understanding regarding the need for action to foster the digital transformation of European businesses, including both SMEs and large enterprises. Interreg Europe, co-funded by the European Union, is a European cooperation program that strives to bring together the different regional and local government authorities to develop sustainable and innovative solutions to overcome regional developmental challenges. Their program policy aims to provide an overview of their good practices and measures for fostering the digital transformation of SMEs, focusing on traditional sectors and SMEs with low digital maturity. Many European businesses plan to adopt new digital technologies as part of the digital transformation trend, which is expected to aid the manufacturing execution system in life sciences market growth in the future.
Rising Application in Cell and Gene Therapy Sector Provides Opportunities for Manufacturing Execution System in Life Sciences Market Growth
Cell and gene therapy is one of the growing divisions of the healthcare sector. The growth in the clinical adoption of advanced cell therapy is one of the major factors raising the demand for personalized medicines. In addition, the growing demand for cell therapy, along with the promise it holds, further raises the requirement for MES solutions. It is seen that cell therapy is moving from a manual-oriented lab environment to identifying production scale principles for making the process more robust and error-free, alongside achieving cost optimization. In the cell therapy process, MES can help automate the tracking of the patient’s blood cells through the system, further offering valuable insights into the treatment modality being developed. Furthermore, electronic verification of the process can improve a lab’s throughput by negating human errors. In addition, the MES solution can also help reduce risk by alerting operators about problems that could have catastrophic consequences. Several market players are providing MES solutions, particularly for cell and gene manufacturing. For example, POMS Corporation provides POMSnet MES. The MES solution helps regulate industry deliveries such as genealogy, material management, and equipment tracking (instruments, safety hoods, centrifuges, and more). Thus, the growing application and adoption of MES by the market players in cell and gene therapy manufacturing is expected to create an opportunity for the manufacturing execution system in life sciences market growth during the forecast period.
The manufacturing execution system in life sciences market is segmented on the basis of offering, deployment, organization size, and application. Based on the offering, the manufacturing execution system in the life sciences market is segmented into software and services. In terms of revenue, service segment commanded a larger manufacturing execution system in life sciences market share in the year 2022.
Based on deployment, the manufacturing execution system in life sciences market is segmented into on-premise and cloud. In terms of organization size, the manufacturing execution system in life sciences market is segmented into SMEs and large enterprises. Based on application, the manufacturing execution system in life sciences market is segmented into pharmaceutical, biotechnology, and medical devices.
The top five manufacturing execution system in life sciences market players operating in 2022 were Korber AG, Siemens AG, Emerson Electric, Rockwell Automation and Dassault Systemes. The positioning of these “Five Key Players” is derived by giving weightage to the following key performance parameters: overall revenue, segment revenue, geographical reach, customer base, new product launches, market initiatives, investment in technology up-gradation, R&D investments, mergers & acquisitions, and other market-related activities. Various other notable manufacturing execution system in life sciences market players profiled in the global report include General Electric, Apprentice FS Inc, ATS Global, Atachi Systems, LZ Lifescience Ltd, POMS Corporation, and Schneider Electric.
Key Findings of Market Study:
Key stakeholders in the manufacturing execution system (MES) in life sciences market include technology enablers, MES solution providers, regulatory bodies, system integrators/service providers, and the life sciences industry. In recent years, the demand for MES has been increasing due to the large-scale adoption of Pharma 4.0 in the life sciences sector. Technology enablers play a crucial role in the rising adoption of cloud MES solutions. They provide platforms to host MES solutions. The platforms also provide access to various third-party applications, which can help customize an MES solution with ease. Siemens, Korber, and Tulip are among the major MES solution providers. System integrators/service providers are third parties that aid pharmaceutical and medical device manufacturers in developing, customizing, integrating, and maintaining an MES solution in their plants. Several service providers have authorizations from multiple MES solution providers to implement the latter’s solutions in a plant and provide support for the same.
Related Reports
- $3,000.00 – $5,000.00
